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EIGHTH PATERSON SYMPOSIUM
ON CONTROL OF PROLIFERATION AND DIFFERENTIATION IN
HAEMOPOIETIC TISSUES
The Eighth Paterson Symposium was
held at the Paterson Laboratories,
Christie Hospital and Holt Radium
Institute, Manchester, from 8-11 October
1973 and took forits topic this year " Control
of Proliferation and Differentiation in
Haemopoietic Tissues ". Contributions
were invited from about 25 people actively
engaged in work in this field.
Several speakers reported work con-
cerning the nature of control of the granulo-
cytic progenitor cells both in vitro and in vivo.
Stohlman (Boston) started with the premise
that granulocytic differentiation is probably
initiated by stimulation of committed pro-
genitors in an analagous fashion to erythro-
poietic differentiation which is initiated by
erythropoietin. Experiments carried out to
expose a feedback regulation from peripheral
blood to the committed progenitors w-ere
described. Oscillation is induced in the
circulating neutrophil population when the
stem cell compartment is reduced by cyclo-
phosphamide orgenetically asinthegreycollie
dog; a log-linear relationship between neutro-
phil concentration in the blood and the
extent ofmyelopoiesis in the shielded limb of
an irradiated animal is observed; the rate of
proliferation of both CFU-C and granulocytic
cells in Millipore chambers increases when
implanted into neutropaenic animals com-
pared with those implanted into normal
animals. The possible role of the " colony-
stimulating factor " (CSF) (necessary for the
growth of granulocytic and macrophagic
colonies by culturing haemopoietic cells in
soft agar) as the in vivo regulator was
suggested. Both Stohlman and Metcalf
(Melbourne) were careful to emphasize that no
proof was yet available to enable a physio-
logical role to be ascribed to CSF with any
certainty. The " neutrophil releasingfactor "
was excluded as a primary regulator. The
monocyte-macrophage system was described
by Stohlman and Metcalf as at least one
source of CSF though Metcalf, Van den Engh
(Rijswijk) and Price (Toronto) also reported
various other sources. Stohlman suggested
that CSF production is initiated by inter-
mittent endotoxin release, either exogenous
or endogenous. He described experiments in
germ-free and conventional irradiated and/or
endotoxin-treated mice which supported his
hypothesis.
McCulloch (Toronto) described the need
for two separate cell types for the growth of
granulocytic cells in culture. One, the true
colony-forming cell (CFU-C) and the other
a cell producing the necessary stimulating
activities (CSA). The two cells are readily
separable by the ability to adhere (or not) to
glass or plastic surfaces. Further the CSA-
producing cells can be further subdivided
into two classes only one of which will
support the growth of CFU-C in suspension
culture. Growth of cells from acute myelo-
blastic leukaemia (AML) will occur in
suspension culture stimulated by molecules
similar to CSA produced by cells analogous
to the normal CSA-producing cells. No
colonies can be produced in agar culture from
AML in relapse. On the basis of these
observations McCulloch suggested that regu-
lation of leukaemic cell production is in part
similar to that in normal granulopoiesis and
he produced models of normal and leukaemic
cell production which incorporated these
findings.
Metcalf showed that growth of colonies or
clusters from AML or CML (consisting ofcells
which are judged to be abnormal by several
criteria) is achieved through CSF, though the
dose-response relationships are also ab-
normal. This has been investigated now in
150 cases of AML and CML in the series
studied. A lipoprotein CSF-inhibitor was
also described by Metcalf who indicated that
the determination of differentiation to either
granulocytes or macrophages is, in part,
dependent upon the relative concentrations
of CSF and its inhibitor. Levels of both are
abnormal in the serum and urine of patielnts
who either have leukaemia, or who have
disease states with a high risk of leukaemia
development. The suggestion is that both
development and maintainance of leukaemia
are associated with regulator anomalies.
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granulocytic cells in suspension culture in a
medium consisting of only Fischer's medium
and horse serum was described by Dexter
(Manchester). The culture is initiated by
allowing a suspension of mouse thymus cells
to establish for at least 24 hours before
adding a suspension of syngeneic bone
marrow cells. A complete granulopoiesis is
present 10 days after the culture is started
and at a time when a culture of bone marrow
alone consists of a few mature polymorphs.
The culture can be maintained for several
weeks by replacing half the medium at
weekly intervals. Maintainance of CFU-S is
not achieved but CFU-C are produced inter-
mittently during the culture period. He
agreed that CSF production in a culture of
thymus cells alone is high. The system
appears to have achieved growth of haemo-
poietic cells for longer than has been claimed
by any other workers.
Metcalf, Van den Engh and Price
(Toronto) presented information concerning
the nature of colony stimulating factors.
Molecular weights of between 15000 and
45000 daltons, depending upon the source,
were reported byMetcalf. All are neuraminic
acid-containing glycoproteins and cannot be
degraded to smaller molecules and still retain
activity. Nevertheless they share common
functional activities. Van den Engh de-
scribed variations in physico-chemical pro-
perties of CSF depending upon the source
from which it is obtained. Those made from
human urine, pregnant mouse uteri and
fibroblast-conditioned medium have been
shown to have similar dose response curves
and similar maximum colony stimulating
activities. Therefore he, also, suggested that
the action ofthese different CSFs is identical.
By experiments in which CSFs from different
sources were mixed in various proportions he
had shown that their activity is simply
additive. On the other hand serum from
endotoxin-treated mice behaves differently,
due to the presence of a colony-enhancing
factor which augments the action of CSF but
cannot act alone. A similar enhancer is
found in rat red cell lysates.
Working with colony-stimulating activity
(CSA) prepared from human leucocyte con-
ditioned medium (LCM) Price showed that it
is heterogeneous in both physical and
biological properties. Two major physical
classes can be recognized, a high MW-CSA
(MW about 35,000) and a low MW-CSA
(MW less than 1330). High MW-CSA
prepared from normal orleukaemicleucocytes
stimulates uptake of3H-thymidine in cultures
of human leukaemic blast cells. Low MW-
CSA from normal human leucocytes stimu-
lates both normal progenitors and those from
leukaemic patients in remission, whereas the
analogous material from leukaemic leucocytes
affects only leukaemic cells and cells from
patients relapsing after chemotherapy. The
specificity of these CSAs from different
sources was further confirmed by experi-
ments performed to demonstrate specific
binding to cells related to the source.
These data extended the work reported by
McCulloch postulating the production of
stimulating factors of different specificity
from normal and leukaemic cell populations.
Further work on leukaemic cell popula-
tions was presented by Mak (Toronto). He
reported the finding of an RNA-dependent
DNA polymerase (reverse transcriptase) in
cells from 6 leukaemic patients in relapse and
in small amounts in 8 patients in firm haema-
tological remission. The leukaemias ex-
amined included AML, ALL and CML. An
increase in the amount ofreversetranscriptase
was found after culture of these cells for 7
days even without conditioned medium.
When cultures were stimulated with medium
conditioned by cells from a patient with
haemachromatosis the levels rose 1-7 to 13
times in the case of patients in relapse and 3
to 90 times in cultures of cells from patients
in remission. When the endogenous reverse
transcriptase activities were analysed on
sucrose density gradients two discrete homo-
geneous bands appeared containing (a) 70s
RNA complex and (b) endogeneous DNA
polymerase activity yielding DNA-RNA
hybrids as products. These properties are
consistent with those described for leuco-
viruses. Further, preliminary EM studies
have revealed the presence ofC-type particle-
like structures in these bands.
The complexity of the stimulating acti-
vities found in leucocyte-conditioned medium
was revealed more clearly in discussion when
it was stated that stimulation of colony
formation, thymidine incorporation and
reverse transcriptase stimulation are not
necessarily all elicited at the same time.
A group of contributions from Frindel
(Paris), Schofield (Manchester) and Tridente
(Verona) attempted to demonstrate co-
operation between cells from the thymus and
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some bone marrow cells. Frindel reported
findings indicating a response ofbone marrow
CFU to antigen stimulation in intact mice
which does not occur in thymectomized mice.
Thymectomy does not lead to any change in
CFU regulation leading to erythropoiesis or
granulopoiesis since the compartments of
erythroid andgranulocyticprogenitorsremain
normal. Since antigen response in the adult
thymectomized mouse still occurs it appears
that CFU stimulation is prevented in these
animals because the thymus cannot effect
differentiation from the CFU (or early
derivatives) in response to feed-back from the
antigen-sensitive cells.
Schofield reported experiments demon-
strating (as other workers have also) that
thymus cells do not inhance spleen colony
formation when added to a syngeneic
marrow suspension injected into irradiated
mice. On the other hand, when live synge-
neic thymus cells (but not irradiated ones) are
injected into sub-lethally-irradiated mice the
number of colonies is increased by about 3
times. When lethally irradiated mice were
injected with a mixture of irradiated bone
marrow or spleen cells and thymus cells the
number of colonies formed is doubled. The
increased colony production is not associated
with increased CFU numbers in those spleens
and the thymus-derived cells do not appear to
effect CFV replication. Colony enhancement
can be achieved in foetal liver cell suspensions
(particularly from very early foetal livers)
without the need to irradiate the haemo-
poietic cell suspensions. It was suggested
that a short range cell-cell interaction occurs
which leads to greater proliferation of com-
mitted cells in the haemopoietic tissues.
Only by killing a proportion of the thymus-
derived cells normally present in haemo-
poietic tissues can this cell requirement be
revealed.
Tridente showed a great enhancement of
3H-thymidine incorporation 24 hours after
HPA stimulation ofa mixture ofthymus cells
(from 7-day old mice) and adult bone marrow
cells, compared with the small effect of
stimulation of either population alone. The
responding cell is in the thymus population
as revealed by experiments in which either
the thymus or marrow cells were blocked
before stimulation. Attempts have been
made to identify the co-operating cell in the
marrow by cell separation techniques which
reveal that it exists in a very small fraction in
the density region 1 065-1070. It is not
associated with the CFU-C nor with the
major peak of theta-positive cells. The
nature of the collaboration is still not under-
stood but this group of papers, and that by
Dexter earlier, pose many questions on the
interaction between cells of the haemopoietic
and lymphoid tissues.
Extending his studies on differential
stimulation of different parts of the haemo-
poietic system, Reissman (Kansas) reported
effects of 19-nortestosterone deconate (19-
ND) and erythropoietin in mice treated with
bis-chlorethyl-nitrosourea (BCNU). BCNU
at a dose of LD10 reduces splenic and
femoral CFU to 50% of controls. Granulo-
poiesis recovered within 5 days but recovery
ofboth CFU and granulopoiesis was markedly
accelerated by daily injections of 19-ND with
no detectable effect on erythropoiesis. This
treatment resulted in granulocyte counts up
to 10 times normal probably by effects upon
the committed granulocytic precursors rather
than on CFU recovery. By daily injections
of erythropoietin normal erythropoiesis was
restored within 3 days whereas without
erythropoietin it remained at 20% of control
for at least 10 days. The stimulatory effects
are presumably on the ERC or pre-ERC
populations since no acceleration of CFU
recovery was produced by erythropoietin.
Genetic defects (in the grey collie dog and
the Sl/Sld mouse) were the basis of studies
reported by Patt (San Francisco) and Wolf
(Seattle), respectively. The cyclic reduction
in neutrophil, reticulocyte and platelet pro-
duction occurs every 12 days but there is a
phase difference between granulocyte deple-
tion on one hand and reticulocyte and
platelet reduction on the other. This, Patt
suggested, is due to a restricted stem cell
population, either in numbers, or functionally
because of high stimulation thresholds. The
periodicity of the cell production was
postulated to be determined primarily by the
neutrophil demand with secondary effects on
the other cell types. Byincreasingneutrophil
demand with prolonged endotoxin treatment,
neutrophil oscillation (and eventually reti-
culocyte and platelet fluctuations to a large
extent) were eliminated but returned when
treatment was stopped. While the actual
defects and mechanisms are not clearly
understood this dog provides a unique
situation for the investigation of haemo-
poietic control mechanisms.
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Wolf, furthering his observations on the
stromal environment of the haemopoietic
tissues showed that the SI/Sld mouse per-
mitted only restricted proliferation even when
associated with normal tissue. Grafting
normal spleen onto Sl/Sld spleen or vice
versa, in vivo, left each half spleen exhibiting
its own characteristic support of haemo-
poiesis irrespective of whether the host was a
normal or SI/Sld mouse. Lodgement of
injected CFU into an irradiated Sl/Sld
appears normal since on transfer of the CFU
from the spleen into an irradiated normal
mouse a normal cross-section of colony types
is obtained. This experiment was criticized
on the basis of the time of transfer which
preceded the final settlement of the CFU.
Implants ofnormal splenic or marrow stroma
(even when irradiated with 1300 rad) into
Sl/Sld spleen stimulate erythropoiesis in the
immediate vicinity of the implant. Whilst
a dispute still continues between micro-
environmental versus stochastic determina-
tion of differentiation some of the data
presented by Wolf were compelling.
The disruption of haemopoietic control
brought about by infection of a mouse with
the Rauscher virus was discussed by Seidel
(Ulm). The effect upon the CFU-S popula-
tion is to increase turnover rate and this is
accompanied by elevation of the CFU-C
population by as much as 30 times after an
initial depression. Erythroblastosis is also a
characteristic feature of the Rauscher virus
infection leading to the suggestion that the
pluripotent stem cell is probably the target of
the virus, with resulting increased different-
iation and turnover. However, the maturation
capabilities of the granulopoietic cells and of
CSF production are both impaired during the
course of infection and leukaemia.
Byron (Baltimore) described work, per-
formed in Manchester, on the induction of
CFU-S into cycle by various steroids, di-
butyryl cyclic-AMP and isoprenaline. He
described experiments which show that the
site of action is on , or /2 adrenergic
receptor sites, depending upon the compound
used; and that the mechanism of initiation
is through the adenyl cyclase system in the
cell. Other experiments show that acetyl-
choline and carbamylcholine can also initiate
DNA synthesis in Go CFU-S and these
compounds appear to operate through choli-
nergic cell surface receptors. It is of interest
that the compounds, whilst tested in short
term in vitro cultures, operate at physio-
logical concentrations. So far nothing is
understood of how these actions can regulate
cell population size but the work described
provides the first hint of the mechanism of
haemopoietic regulation at the level of the
individual stem cell.
The second part of the meeting was
devoted entirely to the problem of specific
proliferation inhibitors ("chalones"?) in the
control of haemopoietic tissue. It fairly
quickly became obvious that different mecha-
nisms were involved in the various systems
described and consequently, rather than use
the word " chalone " and all the connotations
that the word invokes, the term " Specific
Inhibitor " will be used throughout this
report.
Houck (Washington) dealt with the
effectiveness of lymphoid tissue extracts in
inhibiting the incorporation of tritiated
thymidine (3H-TdR) by proliferating cell
systems. He demonstrated the same degree
of effect, irrespective of the source of the
extract (thymus, spleen, lymph node, blood),
on both T and B lymphocyte populations.
He found this effect to be independent of the
method of lymphocyte stimulation. These
observations were all made in vitro but later,
Kiger (Villejuif) showed that although the
specificity of the thymus cell extract, in vitro
is not strikingly different for either T or B
lymphocytes, in vivo the thymus extract
shows a clear specificity for T cells in that
T cell immune reactions (e.g. PHA-lympho-
cyte stimulation, graft versus host reaction
and T and B cell co-operation immune
reactions such as antibody formation) are
depressed while antibody formation against B
cell triggers are not affected. She therefore
concluded that two lymphoid inhibitors
exist.
Houck claimed that the molecular weight
of these inhibitors is in the region of 30,000
to 50,000 daltons and suggested that Kiger's
value ofabout 20,000 daltons is probably due
to an artefactual difference produced by
differences in methodology, i.e. between
Sephadex column chromatography and mole-
cular ultrafiltration.
On the question of binding of lymphoid
extracts tolymphoid cells, Houckshowed that
B cells from a human lymphoblastic tumour
cell line are able to produce as much inhibitor
as cells from any other lymphoid tissue but
are considerably less able to retain the applied
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extract than are normal cells. They are thus
released from inhibition more easily, a finding
which corresponds to that of Rytomaa for
chloroleukaemic cells.
The problem of possible interaction
between PHA and lymphoid extracts was
overruled by the fact that other mitogens
behave similarly to PHA. More important,
extracts are effective on the lymphoblastic
cell line which is highly proliferative without
any mitogen.
In relation to the use oflymphoid extracts
for suppression of GvH reaction, Houck
reported that 5 mg of splenic lymphoid
extract, 3 times/week increases skin graft
survival times from 10-5 days to 29 days, the
inhibitor treatment stopping after 21 days
because of shortage of material. Similar
muscle extracts have no effect on the survival
time.
Garcia-Giralt (Villejuif) devoted himself
entirely to the question of GvH suppression
and demonstrated that treatment of parental
spleen cells (in vivo or in vitro) with a partially
purified spleen extract (S4) increases the
survival time of lethally irradiated Fl hybrid
mice compared with mice injected with
untreated parental cells. The mechanism of
this effect was thought to be that the spleen
extract prevented the parental spleen cells
from responding to the antigenic stimulation
provided by the hybrid recipient. However,
irradiation ofS4 treated mice or S4 treatment
of irradiated mice induces no differences in
the lymphoid organs during repopulation
compared with the non S4 treated animals.
At the same time, splenic lymphocytes from
the S4 treated regenerating mice have a
decreased PHA or pokeweed mitogen trans-
formation rate. Thus, he came to the
conc]lision that S4 does not inhibit the pro-
liferation of lymphocyte precursors but only
the target cells, the immune-competent
cells.
Questions were asked concerning the
toxicity of the extracts. It was suggested
that for something which should essentially
provide a short term effect, long term GvH
suppression is surprising. Garcia-Giralt ad-
mitted this but suggested that lymphoid
extracts bind to the cells preventing trans-
formation. A similar question arose later in
connection with the statement by Laerum
that incubation of bone marrow cells with
granulocyte extracts before plating in agar for
CFU-C assay causes a30-50% loss of colonies
measured 7 days later. It was found difficult
to equate this with anything other than a
direct cytotoxic effect on the CFU-C although
Laerum said the effect can be reversed by
washing the cells before plating.
Rytomaa (Helsinki) introduced the granu-
locyte inhibitor session with a summary of
much of his early work illustrating reduced
3H-TdR labelling indices of granulocyte pre-
cursors in short term bone marrow cultures.
Cell proliferation was shown to be severely
damped while RNA synthesis was not
affected. He further demonstrated a reduced
cellularity and 3H-TdR incorporation of
normal and chloroleukaemic granulocytes
grown in diffusion chambers implanted in
rats bearing chloroma tumours, the effect
being produced by a continuous infusion of
inhibitor released by the tumour.
Using the superior qualities of an in vivo
culture technique afforded by the diffusion
chamber (DC) method, Benestad (Oslo) first
demonstrated some of the characteristics of
DC cell populations. He found that cell
growth is inhibited by large cell densities after
2-4 days, mainly due to the action of local
DC factors. These he tried to mimic using
granulocyte extracts and found that 3H-TdR
incorporation by proliferating granulocytes is
reduced while there is no effect on the
proliferating immunoblasts and macrophages.
Paukovits (Vienna) later showed by bone
marrow cell fractionation studies that inhibi-
tion occurs in all stages of the maturing
granulocytic cell series.
Benestad further showed that injection of
hydroxyurea, a specific S-phase killing agent,
to DC bearing animals reduces the cellularity
of the DC to approximately 50% of control.
A prior injection of granulocyte extract is
able, presumably by S phase suppression or
by blocking entry to S, to protect the cells
from the toxic effects of hydroxyurea and
approximately 80% of the cells survive.
However, because macrophages are also
spared by the inhibitor, he emphasized the
need to start extracting from pure cell
populations. This reinforced a question
raised earlier in connection with the lymphoid
extracts as to the evidence that the active
extract comes from the lymphocytes in view
of the fact that the lymphoid organs contain
such mixed cell populations.
Laerum (Oslo) and Maurer (Tubingen)
employed a new fluorometric technique
which measures the DNA content of single
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cells, 50,000 cells being measured in the space
of2 minutes and being plotted out in the form
of a histogram of DNA content. Using this
method they were able to show effects of
granulocyte extracts on the numbers of cells
in the S and G2 phases of a cell cycle. With
treatment in vivo, they claimed a direct
effect on cells at the G1-S boundary while
treatment in vitro shows, in addition, an
effect on cells in the S phase. Consequently,
as with Kiger's results for the thymic inhi-
bitor, they concluded that one cannot
directly compare the in vitro and in vivo
measurements and that the latter give the
more specific effect.
Paukovits (Vienna) was the only con-
tributor to investigate the chemical nature
of the extracts and to attempt any high
degree of purification. Starting from the
spleen, he made extracts with ethyl alcohol-
acetone mixtures and then made sequential
purifications by column chromatography on
Sephadex G-25, Sephadex G-15 and Biogel
P-6, checking the inhibitory activity at each
stage on a short term bone marrow culture.
These steps were followed by paper electro-
phoresis and thin layer chromatography.
He affirmed that the inhibitor has a molecular
weight of around 2000 to 4000 daltons as
originally reported by Rytomaa and the
resultant material from his purification
procedure was strongly inhibitory in terms
of 3H-TdR uptake but was not quantitated.
He was unable to detect any peptide material
in these samples even with detection methods
working at the 10-12 mol level. On the other
hand, he could inactivate them with proteo-
lytic enzymes such as protease, chymotrypsin
or papain which clearly do indicate the
peptide nature of the purified extracts
Paukovits further warned that thymidine
is a constituent of primary granulocyte
extracts and this may be a complicating factor
in interpreting thymidine incorporation data.
Thiscommenthighlightedarecurrent question
throughout the day concerning the effects of
thymidine which seems to be present even in
some partly purified fractions of cell extracts.
Houck claimed it is a feature of whether the
extract is made from fresh tissue or from
acetone extracted tissue powders. Rytomaa
made estimations ofthe thymidine content of
his extracts to show that very low levels
existed and reported experiments adding
extra thymidine to show that, in his case,
thymidine contamination is not a problem.
Less information was available on possible
erythroid inhibitors although Bateman
(Sussex) demonstrated autoradiographic
evidence ofeffects in short term bone marrow
cultures which supported the early work of
the Finnish group on this subject. The
labelling indices and grain count distributions
oferythroid cells were reduced by application
of the extract while those of myeloid and
lymphoid cells were unaffected. On the other
hand, leucocyte extracts did not affect
erythroid cells.
Peschle (Naples) studied erythroid in-
hibitors in a clinical situation with cases of
pure red cell anaemia (PRCA). Looking at
the serum of these patients he found an
inhibitor to erythropoiesis which is localized
in the IgG serum chromatographic fraction.
During remission produced by immuno-
suppressive therapy, this inhibitor disappears.
He concluded that PRCA is an autoimmune
disease characterized by serum IgG inhibitors
to erythropoiesis exerting a cytotoxic effect
at the erythroid marrow level, sometimes
also acting by neutralizing the circulating
erythropoietin.
Throughout these sessions, most speakers
agreed that the question of specificity of
action of the tissue extracts is of the utmost
importance. In most cases, specificity was
ascertained by taking similarly prepared
extracts from unrelated tissuesfor comparison
and/or testing the extracts in question in
other cell systems. For example, Houck
made brain, muscle and kidney extracts and
made tests on fibroblast, HeLa and chorio-
carcinoma cultures in addition to his lym-
phoid extract/lymphoid culture system.
Garcia-Giralt tested the spleen extract on
CFU-S; Kiger, the thymus extract on liver
slices. Rytomaa put mastocytoma or HeLa
cells in DC as comparison with granulocytic
or chloroleukaemic cells. Laerum used skin
extracts in comparison with granulocyte
extracts. None of these comparisons was
acceptable to the sceptical members of the
audience because of the basically different
nature of the tissues involved. In some
cultures (Rytomaa and Bateman), a close
relationship between the cell types tested
(erythroid and granulocytic) was maintained
but doubt was expressed as to the validity of
measurements in these cultures because ofthe
well recognized " unhappiness " of erythroid
cells with any culture system known.
These problems were, at least in part,
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resolved by the final paper of the session
given by Lord (Manchester). Recognizing
the need to define specificity ofaction ofthese
inhibitors in a clear cut manner he described
a method based on the phenomenon of
fluorochromasia coupled with the technique
offluorescence polarization for measuring the
Structuredness of the Cytoplasmic Matrix of
the cells (SCM). This technique has been
adapted and developed in the Paterson
Laboratories by Drs L. and B. Cercek for
studying the action of various agents on
living cell populations. The SCM of a cell is
a measure of the biophysical state of the
cytoplasm of a cell and Lord demonstrated
how it varies as a proliferating cell proceeds
through its generation cycle. Measurements
of the average value of SCM for any popula-
tion of cells is characteristically low if it is an
asynchronous, proliferating population but
high if its rate of proliferation is low or non-
existent. He then chose to test out the
specificity of the three closely related
haematological cell extracts (erythroid, granu-
locytic and lymphoid) on correspondingly
closely associated cell systems (foetal liver
normoblasts, granulocytic cells in the culture
system earlier described by Dexter and PHA
stimulated lymphocytes). In all three
systems, the only extracts to increase the
SCM are those taken from cells of the same
type as those measured. Furthermore, for
each set of extracts, except possibly the
erythroid ones, the effective extracts were
those in the molecular weight ranges reported
by Houck and Rytomaa. He thus demon-
strated a completely clear cut definition of
specificity of action of haemopoietic cell
extracts but warned that this may not be
related to normal physiological control
mechanisms.
On the question oftoxicity ofthe extracts
which had arisen at various times inthe meet-
ing Lord was further able to demonstrate
that at the dose level used, the effect is
reversible simply by washing the treated
cells. Finally, he pointed out that the
extracts were made from bovine and rat
sources while the test cells came from human
and mouse sources. Thus, another criterion
of the " specific inhibitor concept ", that of
non-speciesspecificity, couldbedemonstrated.
The content of this symposium, when
compared with a similar one held in the same
laboratories 6 years ago, indicates the rapid
advances made in this field in the past few
years. The understanding of control of cell
populations is fundamental to the under-
standing of the mechanisms of malignant
processes and it is clear that in the haemo-
poietic tissues major progress has been
achieved. Thissymposium, ofcourse,revealed
large areas which are, as yet, not understood
and in which techniques are not available for
investigation. An encouraging feature, on
the other hand, was the beginning oftransfer
of information and techniques from experi-
mental animals to the study of human
disease. The final impression is that the
momentum of research in this field by
relatively few workers is encouraging and one
might anticipate that a much clearer under-
standing of the mechanisms of control of
haemopoietic populations and their involve-
ment in haematological disorders will be
available within the next few years.
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